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Abstract
The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that is activated by
a structurally diverse array of synthetic and natural chemicals, including toxic halogenated
aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Analysis of the
molecular events occurring in the AhR ligand binding and activation processes requires structural
information on the AhR Per-Arnt-Sim (PAS) B-containing ligand binding domain, for which no
experimentally determined structure has been reported. With the availability of extensive
structural information on homologous PAS-containing proteins, a reliable model of the mouse
AhR PAS B domain was developed by comparative modeling techniques. The PAS domain
structures of the functionally related hypoxia-inducible factor 2α (HIF-2α) and AhR nuclear
translocator (ARNT) proteins, which exhibit the highest degree of sequence identity and similarity
with AhR, were chosen to develop a two-template model. To confirm the features of the modeled
domain, the effects of point mutations in selected residue positions on both TCDD binding to the
AhR and TCDD-dependent transformation and DNA binding were analyzed. Mutagenesis and
functional analysis results are consistent with the proposed model and confirm that the cavity
modeled in the interior of the domain is indeed involved in ligand binding. Moreover, the
physicochemical characteristics of some residues and of their mutants, along with the effects of
mutagenesis on TCDD and DNA binding, also suggest some key features that are required for
ligand binding and activation of mAhR at a molecular level, thus providing a framework for
further studies.
The aryl hydrocarbon receptor (AhR)1 is a basic helix–loop–helix (bHLH), PAS- (Per-Arnt-
Sim-) containing transcription factor which is present in numerous species and tissues and
activates gene expression in a ligand-dependent manner (1–3). While the AhR can bind and
be activated by a large number of structurally diverse chemicals (4–6), the highest affinity
ligands include halogenated aromatic hydrocarbons (HAHs), such as 2,3,7,8-
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tetrachlorodibenzo-p-dioxin (TCDD, dioxin), and polycyclic aromatic hydrocarbons
(PAHs), both widespread classes of environmental contaminants (4,7). Mechanistically, the
inducing chemical diffuses across the plasma membrane and binds to the cytosolic AhR
which exists as a multiprotein complex containing two molecules of hsp90 (a heat shock
protein of 90 kDa), the X-associated protein 2 (XAP2), and the cochaperone p23 (8).
Following ligand binding, the AhR is presumed to undergo a conformational change (9),
exposing an N-terminal nuclear localization sequence that leads to translocation of the
liganded AhR complex into the nucleus (10). Dissociation of the AhR from the protein
complex and its dimerization with ARNT (AhR nuclear translocator) convert the AhR
complex into its high-affinity DNA binding form (11). Binding of the ligand–AhR–ARNT
complex to its specific DNA recognition site, the dioxin responsive element (DRE), leads to
an increase in transcription of the adjacent gene (2,3,12).
Among the various domains of the AhR that exhibit distinct functional activities (1,13–15),
we have primarily focused our attention on that of PAS B, one of the two structural repeats
(PAS A and PAS B) within the PAS domain, that is involved in both ligand and hsp90
binding. In contrast to the significant amount of information available regarding AhR
ligands, essentially nothing is known about the AhR ligand binding domain (LBD) itself.
Full ligand binding activity and specificity of the mouse AhR are reportedly contained
within a small fragment (residues 230–421), and several naturally occurring mutations
within this region reduce AhR ligand binding affinity (13,16,17). Moreover, deletion of
residues 287–421 results in a ligand-independent constitutively active AhR consistent the
role of the AhR LBD–hsp90 complex in regulating AhR functionality (18).
Analysis of the molecular events that result from AhR ligand binding requires detailed
structural information; however, no X-ray or NMR-determined structure of ligand-bound or
unliganded AhR has been reported. Moreover, structural information on homologous PAS-
containing proteins that could be effectively used for comparative modeling purposes was
not available until 1998. Once the first crystal structures of distant homologous proteins
belonging to the PAS superfamily became available [the bacterial photoactive yellow
protein, PYP (19,20), the PAS domain of the human potassium channel HERG (21), and the
heme binding domain of the bacterial O2 sensing FixL protein (22)], we developed the first
theoretical model for the LBD of the mouse AhR (mAhR) by applying homology modeling
techniques (23). Despite the low level of sequence similarity, the structures of those three
PAS domains showed highly conserved structural characteristics. At the time, our analysis
suggested FixL as the best template for homology modeling. The resulting model showed
consistency with available experimental data, thus providing an initial framework to make
hypotheses on the LBD characteristics and functionality of the AhR (6,24). The subsequent
determination of the X-ray structure of the PAS domain of the fern photoreceptor Phy3 (25)
improved the knowledge on this superfamily and highlighted the presence of different
arrangements of the secondary structure elements in the known PAS structures. This insight
also provided an avenue for revising the first mAhR LBD model (26), but a more reliable
proposal for the structural features of the AhR LBD could not be obtained until the
structures of homologous proteins with higher sequence identity to the AhR became
available.
1Abbreviations: AhR, aryl hydrocarbon receptor; bHLH, basic helix–loop–helix; PAS, Per-Arnt-Sim; LBD, ligand binding domain;
HAH, halogenated aromatic hydrocarbon; PAH, polycyclic aromatic hydrocarbon; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin;
TCDF, 2,3,7,8-tetrachlorodibenzofuran; hsp90, heat shock protein of 90 kDa; XAP2, X-associated protein 2; PYP, photoactive yellow
protein; ARNT, AhR nuclear translocator; hPASK, human PAS kinase; HIF-2α, hypoxia-inducible factor 2α; NcoA, nuclear
coactivator 1; dPER, Drosophila clock protein PERIOD; FMN, flavin mononucleotide; DRE, dioxin responsive element; HRE,
hypoxia responsive element.
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In the last 4 years an impressive growth of structural and functional knowledge on PAS
domains has been obtained. During that time, a number of PAS structures were derived by
NMR spectroscopy or X-ray diffraction, including the N-terminal PAS domain of human
PAS kinase, hPASK (27), the C-terminal PAS B domain of human hypoxia-inducible factor
2α, HIF-2α (28), the PAS B domain of the mouse nuclear coactivator 1, NCoA (29), an N-
terminal fragment of the Drosophila clock protein PERIOD, dPER, including the two PAS
repeats (30), and the PAS B domain of the human ARNT protein (31). Some of these
structures deserved particular attention as the full-length proteins share some key functional
similarities with AhR. Both HIF-2α and ARNT, like the AhR, belong to the bHLH/PAS
family of transcriptional factors that are key regulators of gene expression networks
underlying many essential biological processes (32). In order to become transcriptionally
active, AhR and HIF-2α must directly sense environmental signals (exposure to xenobiotic
compounds for AhR and hypoxic conditions for HIF-2α), the PAS domains of both proteins
associate with hsp90, and in both cases, their heterodimerization with ARNT appears to be
required for release of chaperone proteins and conversion of the dimeric complexes into
their DNA binding form. Finally, binding of the AhR–ARNT and HIF-2α–ARNT
complexes to their distinct but related specific E-box-like DNA recognition sequences, the
DRE and the HRE (hypoxia responsive element), respectively, stimulates expression of
adjacent genes. Given these commonalities in response, examination of the PAS B domains
of HIF-2α and ARNT, the most functionally related proteins, reveals that they have the
highest degrees of sequence identity and similarity with that of AhR among all the PAS
structures reported to date.
Following the new data and intriguing insights into the characteristics of PAS domains, the
aim of this paper is the structural and functional characterization of the LBD of mAhR
through rational mutational analysis guided by a reliable theoretical model. Therefore, an
updated model of the mAhR PAS B domain was built by comparative modeling techniques.
To validate our proposed model, site-directed mutagenesis of amino acids in key positions
within the modeled LBD was performed, and the effects of these mutations on the mAhR
ligand binding and ligand-dependent DNA binding were examined.
MATERIALS AND METHODS
PAS Domain Template Structures
Structures of the PAS domains currently available were obtained from the Protein Data
Bank (33). The specific X-ray structures selected for the photoreceptors were those
representing the dark state, and for FixL we selected the unbound state. When different
depositions were available, the structure with the highest resolution was selected for use as
the template. In addition, the most representative structure within each of the NMR structure
bundles was selected using the NMRCLUST program (34). The PDB identification numbers
of the selected PAS structures used in our analysis are presented in Table 1.
Homology Modeling
Homology modeling techniques were applied to predict the structure of the LBD of the
mouse AhR, mAhR (GI: 7304873 in the NCBI sequence database), focusing on a fragment
between amino acids 230–421 that was reported to contain the full ligand binding activity
and specificity (13). Sequence similarity searches with the AhR LBD were performed using
PSI-BLAST (36) against a database of known protein structures with default parameters.
The three-dimensional models for the wild-type and mutant mAhR LBDs were generated
using MODELLER version 8v1 (37–39), which implements an approach to comparative
modeling by satisfying spatial restraints, and these are extracted from the alignment of the
target sequence with the multiple template structures. The restraints, which were obtained
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empirically from a database of protein structure alignments, and CHARMM energy terms
(40) were combined into an objective function. The resulting model was obtained by
optimizing the objective function, employing methods of conjugate gradients and molecular
dynamics with simulated annealing.
The templates were pairwise structurally aligned according to DALILite (41,42), using
HIF-2α as a reference. The sequence alignments were obtained by CLUSTALW (43), and
the result was confirmed using the Align-2D command within the MODELLER program
(37–39). This generated an alignment of sequences with structures using a variable gap
opening penalty that favors gaps in exposed regions and avoids gaps within secondary
structure elements. The secondary structure of the AhR LBD was then predicted by
PSIPRED (44).
The quality of the models was assessed by different validation methods. General features
were evaluated on the basis of the MODELLER’s ENERGY scores and violation restraint
lists while detailed reliability indexes were obtained by the PROCHECK program (45).
Moreover, the PROSA z-score was calculated using PROSAII (46) and employed as a
quality index, with a more negative z-score indicating a better structural model. Each z-score
was then normalized using the natural logarithm of the sequence length, and an estimate of
the probability that the model was reliable (pG value) was derived by comparison with
expected normalized Q-scores for known structures of the same length (47). Final three-
dimensional visualization and images of the AhR LBD structure were generated using
PyMOL (48).
Characterization of Structural Pockets and Cavities
Identification and characterization of surface pockets and internal cavities in template and
model structures were performed by the CASTp server (49). The program allows
identification and calculation of Connolly’s molecular surface and volume (50) for all
pockets and cavities in a protein structure. It ranks the cavities by size, where the largest one
is usually the binding site (49). The representations of the surface including the largest
available cavity were produced with PyMOL (48).
Molecular Dynamics Simulations
The modeled structures of the wild-type and I332P mutant mAhR LBDs were subjected to
molecular dynamics (MD) simulations. These were performed with GROMACS 3.3 (51,52),
by using the GROMOS96 43a2 version of the GROMOS force field as available in the
GROMACS package. Structures were solvated in SPC water using cubic boxes and
simulated with periodic boundary conditions. The dimensions of the box were set to allow at
least 0.8 nm between protein and box faces on each side. Solvent was relaxed with 5 ps MD
simulation, keeping protein degrees of freedom restrained. After addition of ions to
neutralize the systems, a short minimization with steepest descent was performed up to
convergence on maximum force lower than 1000 kJ/(mol·nm). The resulting systems were
employed as starting points for simulations. These were carried out in the NPT ensemble for
1 ns. Different random seeds were employed to generate different starting velocities from a
Maxwellian distribution at 300 K. For long-range electrostatic interactions, the particle mesh
Ewald summation method (53) was employed to gain a more accurate description. Van der
Waals interactions were described by a 6–12 Lennard-Jones potential with distance cutoff at
0.9 nm; neighbor lists were employed with a list cutoff of 0.9 nm and update frequency
every 10 steps.
Protein and solvent were independently coupled with a thermal bath by a Berendsen
thermostat at 300 K and a coupling period of 0.1 ps. The internal degrees of freedom of
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water molecules were constrained by the SHAKE algorithm (54), and all bond distances in
the proteins were constrained by the LINCS algorithm (55).
All of the analyses on trajectory data were performed with GROMACS. The centroid
structure of the largest cluster in I332P trajectory was employed for representation in Figure
7.
Mutagenesis and Ah Receptor Functional Analysis. (A) In Vitro Protein Expression and
Mutagenesis
The mouse AhR expression plasmid pcDNA3/βAhR, obtained from Dr. Oliver Hankinson
(University of California, Los Angeles), and the mouse ARNT expression plasmid
pcDNA3.1-mARNT (56) were used as templates for expression of the AhR and ARNT.
AhR and ARNT were synthesized in vitro using the TNT Quick coupled transcription/
translation rabbit reticulocyte lysate system (Promega) as previously described (56).
Mutation of selected amino acids within the AhR to alanine (R282, H285, T311, C327,
M334, E339, K350, and Q377), proline (I332), valine or leucine (A375), or glutamic acid
(M334) was carried out using the QuickChange mutagenesis technique (Stratagene).
Translation grade L-[35S]-methionine (>400 Ci/mmol) was purchased from MP Biomedical
(Solon, OH). 35S-Radiolabeled wild-type and mutant mAhRs were synthesized in separate
reactions in vitro, denatured, and subjected to SDS–polyacrylamide gel electrophoresis, and
the level of expression of each protein was determined by autoradiography of the dried gel.
(B) Synthetic Oligonucleotides and Gel Retardation Analysis
A complementary pair of synthetic oligonucleotides containing the sequences 5′-
GATCTGGCTCTTCTCACG-CAACTCCG-3′ and 5′-GATCCGGAGTTGCGTGAGAA-
GAGCCA-3′ (corresponding to the AhR binding site of DRE3 and designated as the DRE
oligonucleotide) was synthesized, purified, annealed, and radiolabeled with [γ-32P]-ATP
[6000 Ci/mmol (Amersham)] as described (57). Aliquots of in vitro synthesized mouse
ARNT and wt AhR or mutant AhR (1.5 µL each) were combined with 7 µL of MEDG
buffer [25 mM MOPES, pH 7.5, 1 mM EDTA, 1 mM DTT, and 10% (v/v) glycerol] and
incubated in the presence of 20 nM TCDD or DMSO solvent control for 1.5 h at room
temperature. Aliquots of the incubation reaction were mixed with [32P]DRE oligonucleotide,
and gel retardation analysis was carried out as previously described (56,57). Protein–DNA
complexes in the dried gels were visualized, and the amount of 32P-labeled DRE present in
the TCDD-induced protein–DNA complex was quantitated by phosphorimager analysis
(Molecular Dynamics). The amount of radioactivity present in the induced protein–DNA
complex in the TCDD-treated lane (the TCDD–AhR–ARNT–DRE complex) minus that
present in the same position in the DMSO-treated sample lane represented the amount of
specific TCDD-inducible AhR–ARNT–[32P]DRE complex. Given that multiple gel
retardation assays had to be run to analyze the DNA binding activity of mutant AhRs,
mutant DNA binding results were normalized to results obtained with wt AhR in each
experiment and expressed as a percentage of the amount of TCDD-inducible wt AhR DNA
binding.
(C) Hydroxyapatite [3H]TCDD Binding Assay
[3H]TCDD (specific activity 14.5 Ci/mmol) and 2,3,7,8-tetrachlorod-ibenzofuran (TCDF)
were provided by Dr. S. Safe (Texas A&M University). An aliquot (25 µL) of in vitro
synthesized AhR reaction mixture was diluted to 100 µL with MEDG buffer and incubated
with 2 nM [3H]TCDD in the absence or presence of 200 nM TCDF for 2 h at room
temperature. In selected experiments in vitro synthesized wild-type and mutant AhRs were
incubated with 20 nM [3H]TCDD as described above. Binding of [3H]TCDD to the AhR
was determined using the hydroxyapatite binding assay as described (57). The specific
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binding of [3H]TCDD to the wild-type and mutant AhRs was computed by subtracting the
amount of [3H]TCDD bound in the presence of TCDF from the amount of [3H]TCDD
bound in the absence of competitor. In experiments with 20 nM [3H]TCDD, specific binding
was determined by subtracting the amount of [3H]-TCDD bound to an identical
concentration of unprogramed lysate from the total amount of binding to lysate containing in
vitro expressed AhR. The amount of [3H]TCDD specific binding to each mutant AhR was
expressed as a percent of the total [3H]TCDD specific binding to wt AhR.
RESULTS AND DISCUSSION
Choice of the Template Structures and Alignment
To select the best template structures for modeling the AhR PAS B LBD, we considered all
of the available PAS domain structures at that time (Table 1, Figure 1). Besides the high
ductility in signal responses developed by the PAS domains (59), these show a high
structural conservation of the α and β folds. This includes a five-stranded β-sheet and a long
central helix (helical connector) generally linked to a bulge of three small helices. Following
the nomenclature established for FixL (22) and generally adopted for PAS structures in the
literature (Figure 2a), the N-terminal β-strands are referred to as Aβ and Bβ, followed by
three small helices (Cα, Dα, and Eα), the helical connector (Fα), and the three C-terminal
strands of the β-sheet (Gβ, Hβ, and Iβ).
It can be observed in the different PAS domain structures in Figure 1 that the helical
connector is displaced from the β-sheet in different ways, designing, in some cases, a cavity
suitable for arranging different kinds of cofactors. While PYP includes the covalently bound
4-hydroxycinnamic acid within the N-terminal α-helical cap (including Cα, Dα, and Eα), in
FixL the heme cofactor lies in the center of the domain and points to a wide entrance offered
by the Fα helical connector, the following Gβ strand, and their interconnecting loop (the FG
loop). In contrast, in Phy3, the flavin mononucleotide (FMN) cofactor is noncovalently
bound in the middle of the domain and protrudes from it on the opposite side of the helical
connector (as compared to heme in FixL), which results in greater space between the helical
connector (Fα) and the Cα, Dα, Eα group. Among the PAS domains that do not bind
cofactors, the hPASK secondary structure arrangement resembles that of FixL, with the only
difference being a more extended FG loop between a shortened helical connector and the Gβ
strand, while the arrangements of HIF-2α, ARNT, dPER, and HERG structures are similar
to that observed in Phy3. In NCoA, the helical connector position resembles those of the
latter group of domains, but the length and the arrangement of the other helices are different.
On the basis of these observations, it emerges that the choice of the template structures is
crucial for modeling the AhR PAS B LBD. The overall fold characteristics could be
reproduced independently from the choice of the template; however, the length of the
connecting loops and the resulting relative positions of the helices with respect to the β-
scaffold, as well as the presence and the location of a binding pocket, would be modeled in
significantly different ways depending on the structure selected as the template.
The two most critical issues in homology modeling are the degree of similarity between the
target sequence and the templates and the reliability of the alignment, two aspects that are
intrinsically interconnected (60). By applying a recursive PSI-BLAST search of the mAhR
LBD sequence (residues 230–421) against the PDB database, the only sequence producing a
significant alignment in the first cycle was that of the HIF-2α PAS domain, while
statistically significant homologies with the HIF-2α (E-value = 2 × 10−46), dPER (E-value =
9 × 10−41), and ARNT (E-value = 5 × 10−39) PAS domains were detected after three
iterative cycles. On the basis of these results, HIF-2α appeared to be the more optimal
reference sequence/structure for initial AhR alignment.
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Known AhR sequences were first aligned internally and then aligned to the HIF-2α template
using CLUSTALW, and this final alignment was in complete agreement with that generated
using the Align-2D command within MODELLER (data not shown). A global alignment
was subsequently generated by structural alignment of each of the known PAS templates
with the PAS B HIF-2α by DALI, and the pairwise sequence identities and similarities
between the target mAhR LBD and nine PAS domains are presented in Table 2. The highest
sequence identity and similarity to the mAhR was that of HIF-2α (31.1% and 62.1%,
respectively), followed by ARNT (21.2% and 53.8%, respectively), whereas pairwise
identities with all other sequences were below 20% and similarities below 50%. These data
are in agreement with the knowledge about functional similarities across the PAS
superfamily, suggesting HIF-2α and ARNT as the most informative template structures.
It is likely that the first models we derived for the mAhR LBD, based on the only available
PAS structures at that time [with FixL (23) and Phy3 (26) as templates], were not optimal
due to the low degree of sequence similarity with the templates and the consequential
uncertainty in the alignment of some regions. While we were confident about the conserved
fold characteristics of the initial modeled mAhR LBD, it was clear that the resolution of the
models did not allow us to reliably detect more subtle details such as loop lengths and
secondary structure arrangements. Accordingly, additional experimental information was
needed to further refine the homology models for use in development of structural
hypotheses.
With the availability of more PAS structure information, in combination with the
significantly higher degree of sequence identity and similarity exhibited by HIF-2α and to a
lesser extent by ARNT, the possibilities of alignment uncertainties are reduced. Analysis of
the global sequence alignment of the mAhR LBD with HIF-2α and ARNT PAS B (Figure
2b) reveals few insertions or deletions among these domains within the aligned region
(mAhR residues 278– 384). The only region of the mAhR PAS B that shows slight
variability is in the DE loop, which contains a glycine insertion, and in the HI loop, where a
two-residue deletion is observed. A single residue deletion in the same position in the FG
loops of both mAhR and HIF-2α with respect to ARNT is also revealed by our alignment.
As a consequence, it was possible to define a unique optimal sequence alignment of mAhR
based on the HIF-2α template, and it is conceivable that this coincides with a structural-
based alignment. Moreover, no explicit effort was needed to undertake loop modeling.
Interesting elements also emerge from the analysis of similar residues among mAhR,
HIF-2α, and ARNT as well as from comparison of the secondary structures of these
templates with those predicted for mAhR by PSIPRED (see Figure 2b). While the majority
of similar residues are shared by all three sequences, in some cases the inclusion of the
ARNT sequence provides some additional information to support the alignment. This is
mainly observed in the region from the middle of the helical connector to the end of the C-
terminal β-strands. Additionally, differences in the alignment among the predicted
secondary structures of mAhR and those of the templates occur in three places: the length of
the Bβ strand of mAhR seems to be in better agreement with that of ARNT, Eα is more
similar to that of HIF-2α, and the FG connection appears to differ slightly from both
templates. As a consequence, it is conceivable that the inclusion of additional template
structures besides HIF-2α in the modeling procedure, and in particular that of ARNT, could
help to further improve and refine the model.
Modeling and Model Validation
On the basis of the above observations, three different mAhR PAS B LBD models were
developed and used to test the influence of choice of the templates on the quality of the
modeled structure (Figure 3a). The first model used only the HIF-2R template since it had
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the greatest sequence similarity (mod_HIF-2α); the second used both HIF-2α and ARNT
templates (mod_HIF/ARNT); the third used eight of the PAS structures reported in Figure 1
(mod_8templates); PYP was excluded because of its very low degree of sequence similarity.
To test each possible structure, 100 individual models were derived by MODELLER from
random generation of the starting structure, and the representative model was selected by the
lowest value of the objective function. The quality of each final model was evaluated by
MODELLER’s ENERGY command, to verify if the model satisfies most restraints used to
calculate it, and additionally by the PROCHECK and the PROSAII programs.
A limited number of violations of the MODELLER stereochemical restraints were observed
for all of the models; these violations cannot be avoided given the medium–low degree of
similarity of mAhR with the templates included. Also, the models passed all criteria
implemented in PROCHECK: ~87% of residues reside in the “most favored” areas of the
Ramachandran plot (90% for structures solved at ≤2.0 Å resolution), with only one residue
(HIS320) scored in “disallowed” regions within the first two models; the overall G-factors,
measuring stereochemical quality, range from −0.2 to −0.1 [from −0.5 to 0.3 for structures
solved at 1.5 Å resolution (61)]. The values of the PROSA z-score for the three tests are
reported in Table 3. On the basis of the pG value (47), the threshold value for the z-score
associated with a good quality model for a sequence length of 107 amino acid residues is
−4.05, and models with higher z-scores were considered poor models. The average z-score
for the 100 models generated by MODELLER and the score for the model with the best
objective function indicated that mod_HIF/ARNT and mod_8templates were good quality
models. Conversely, the values obtained for the mod_HIF-2α were near to the limit of
acceptability. On the basis of this evaluation the reliability of both of the multitemplate
models was very similar, but slightly better than the model based on HIF-2α alone. On the
other hand, the three models show very similar fold features, as shown by the root mean
square distance (RMSD) between the positions of CR: 0.34 and 0.76 Å between the
mod_HIF-2α and the mod_HIF/ARNT and mod_8templates, respectively, and 0.69 Å
between the two multitemplate models. To put these differences into perspective, it has to be
considered that the 1 Å accuracy of main-chain atom positions corresponds to X-ray
structures defined at a resolution of about 2.5 Å and that differences between the highly
refined X-ray and NMR structures of the same protein also tend to be about 1 Å (61). As can
be evidenced by the visual comparison of the three modeled structures in Figure 3a, the
slight variability among the models mainly involves the length and stereochemistry of the
Bβ and Gβ strands and the arrangement of some connecting loops.
Due to the low reliability based on the evaluation by PROSAII, we excluded the model
based only on the HIF-2α structure for the following analyses, and considering that only
marginal differences were found between the model based on the combined HIF-2α/ARNT
structures and that obtained using the eight PAS domain structures, we concentrated on the
HIF-2α/ARNT two-template model (mod_HIF/ARNT). This model is shown in different
orientations and representations in Figure 3b.
The analysis of structural pockets and cavities, performed by the CASTp server, indicated
the presence of a buried cavity in the core of the modeled domain, with a volume of 496 Å3,
which falls in the observed range (100–800 Å3) for protein binding pockets or cavities (62).
As shown in Figure 3b, the cavity, represented by the molecular surface including the
available volume, is placed just in the middle of the domain, delimited by the β-sheet and
flanked by the helical connector, the Dα and Eα helices, and the connecting loops.
Interesting observations emerge from the comparison of this result with those obtained by
the same analysis for all of the PAS domain structures considered (Table 1 and Figure 1). In
agreement with the presence of the heme and FMN cofactors, in both FixL and Phy3 PAS
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domains a large pocket is found (985 and 716 Å3, respectively). In both cases this presents a
wide-mouth opening that, accordingly to the cofactor position, lies between the helical
connector and the following Gβ strand, in FixL, and between the helical connector and the
Cα, Dα, Eα group, in Phy3. On the contrary, in the HIF-2α and ARNT PAS structures only
small cavities with volumes smaller than 100 Å3 were found. These results confirm that in
the HIF-2α and ARNT template structures the domain interior is well packed, whereas the
modeled mAhR PAS B domain has enough internal space available for ligand binding.
Interestingly, very similar three-dimensional arrangements of the main chains in the mAhR
model and in the templates generate very different internal spaces, depending on the
different volume occupied by the side chains of not conserved residues. In particular, among
the boundary residues of the mAhR cavity, four residues (P291, I319, C327, L347) have
considerably smaller side chains than the ones in corresponding positions of HIF-2α (see
Figure 2b). Comparing the mAhR and HIF-2α structures, it is clear that the difference in the
empty internal space of the two domains is mainly due to those residues.
On the basis of the above observations and the fact that the PAS structures used for
modeling were not resolved with bound hsp90, it can be concluded that the proposed mAhR
LBD model can be viewed as more appropriate to describe the structural features of the
ligand-bound form of mAhR. It is conceivable that the buried cavity can be made available
for binding thanks to conformational changes in flexible regions of the domain allowing a
“mouth opening” for ligand approach.
Because the model represents the activated state of the mAhR LBD, the domain is expected
to describe also a conformation in which hsp90 has been already partially displaced. This
supports the assumption that modeling the PAS B domain does not necessarily require
inclusion of information from the interacting patches with the chaperone protein.
Furthermore, the high conservation of the PAS fold architecture increases the reliability of
independently modeling the single domain.
Experimental Testing and Model Validation
While the above analysis provides us with a model of the mAhR LBD, validation of such a
model requires experimental confirmation. Accordingly, site-directed mutagenesis and AhR
functional analysis were used to test and confirm the features of the whole modeled domain
as well as the location of the binding cavity. Some specific residues (Table 4) were selected
to examine the effects of point mutations on both [3H]TCDD binding to the AhR and
TCDD-dependent transformation and DNA binding. The rationale for these choices is
readily apparent by examining the residue positions in the modeled three-dimensional
structure as shown in Figure 4. Some of them, namely, Arg282, Thr311, Glu339, and
Lys350 (shown in blue), have side chains pointing outside the modeled LBD, and it is
expected that their mutation does not affect ligand binding. Conversely, His285, Cys327,
Met334, Ala375, and Gln377 (shown in purple) were selected among the boundary residues
of the cavity identified in the LBD with side chains pointing inward, to validate it as the
active site in the LBD. The role of each of these residues in ligand binding could be related
to the side-chain steric effects on the size and shape of the cavity or to particular
stereoelectronic requirements useful for stabilizing the ligand association. To examine this
aspect, different types of amino acid substitutions were inserted at a targeted amino acid
(Met334 and Ala375). Finally, mutation of Ile332 (shown in yellow) to proline was planned
in order to test the structural role of the helical connector, as it is likely that the inserted
proline would act to break the helical arrangement, thus causing a significant structural
change in the overall fold of the domain.
Gel retardation analysis of in vitro synthesized wt AhR and ARNT incubated with TCDD
resulted in the formation of an inducible protein–DNA complex compared to a sample
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incubated with DMSO carrier solvent (Figure 5, lanes 1 and 2). This inducible protein-DNA
complex represents the TCDD–AhR–ARNT–[32P]DNA (56), and it is not observed when
DNA binding reactions contained either unprogrammed lysate, in vitro expressed AhR
alone, or ARNT alone (data not shown). Analysis of the ability of each in vitro synthesized
mutant mAhR to transform and bind to [32P]-DRE-containing DNA in a TCDD-inducible
manner is shown in Figure 5, and quantitation of the amount of TCDD-inducible DNA
binding by each mutant mAhR was determined by phosphorimager analysis of multiple gel
retardation assays with each mAhR and presented in Table 4. Since each mAhR was
synthesized in reticulocyte lysate at similar levels [based on comparable levels of expression
of in vitro synthesized [35S]-wt and mutant mAhRs (Figure 6)], the observed differences in
DNA binding are not simply due to differences in expression levels of each mAhR. Gel
retardation analysis revealed that while some mutations had no significant effect on TCDD-
inducible DNA binding (R282A, T311A, and K350A), some mutations reduced AhR DNA
binding (C327A, M334A, E339A, A375V, and Q377A) and others completely eliminated
DNA binding (H285A, I332P, M334E, and A375L). Interestingly, while the amount of
transformation and DNA binding of mAhR containing the R282A mutation was greater than
that of wt AhR in several gel retardation analyses, it was not significantly different when all
DNA binding data were combined.
While the DNA binding results clearly demonstrate that a variety of mutations within the
AhR PAS B LBD adversely affect the ability of TCDD to stimulate AhR DNA binding, gel
retardation analysis does not identify the actual mechanistic effect of the mutation. Mutation
of a key amino acid could reduce the amount of AhR DNA binding by adversely affecting
the ability of TCDD to bind within to the AhR LBD and/or to make key contacts within the
ligand binding cavity necessary to stimulate ligand-dependent transformation of the AhR
into its DNA binding form (i.e., ligand-dependent release of hsp90 from the AhR and its
subsequent dimerization with ARNT). In order to attempt to differentiate between these
possibilities, we examined the ability of [3H]-TCDD to specifically bind to each of the in
vitro expressed mAhRs. As observed in the gel retardation results, mutation of the AhR
LBD produced a similar range of effects on [3H]-TCDD specific binding (Table 4). As
expected, no decrease in [3H]TCDD specific binding was observed with the mutant AhRs
that exhibited wild-type AhR TCDD-inducible DNA binding (i.e., R282A, T311A, and
K350A). The loss of AhR DNA binding activity with the H285A, I332P, M334E, and
A375L mutations correlated well with the lack of [3H]TCDD specific binding to these
mutant AhRs. These results are consistent with a role for these amino acids in binding of
TCDD within the AhR LBD. The decrease in [3H]TCDD specific binding to mutants
C327A, M334A, and Q377A also correlated well with the reduced DNA binding activity of
these mutants and supports a role for these residues in TCDD binding to and transformation
of the AhR. In these cases, the decrease in ligand binding is presumed to be a consequence
of reduced TCDD binding affinity; however, this remains to be confirmed. Our results also
revealed that two mutations (A375V and E339A) display some unusual characteristics
(Table 4). While in vitro expressed mAhR containing the A375V mutation exhibits no
[3H]TCDD specific binding, it binds to DNA in a TCDD-dependent manner, albeit to ~40%
of that of wt AhR. This apparent discrepancy may result from several technical issues with
regard to the ligand and DNA binding assays. First, the [3H]-TCDD ligand binding assay is
much less sensitive than that of the gel retardation assay. The ligand binding assay uses
[3H]TCDD with a specific activity 14.5 Ci/mmol, while the DNA binding assay uses
[32P]DNA with a specific activity of ~5000 Ci/mmol, and as such, it would be easier to see
[32P]DNA binding to TCDD–AhR complexes compared to [3H]TCDD binding to the AhR.
Second, and more likely, is that previous studies have not only demonstrated that mutation
of alanine 375 to valine reduces TCDD binding affinity by about 10-fold (from ~1 to ~10
nM), but also demonstrated that reagents typically used in AhR ligand binding assays (i.e.,
Tween 80 detergent in the HAP assay and charcoal in other AhR assays) can strip ligand off
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of low-affinity AhRs (57). Since the AhR from species that contain the A375V mutation
naturally (i.e., human and DBA mice) can still function normally in a TCDD-dependent
manner, albeit higher TCDD concentrations are required (6,16,17,24,63), it must still bind
ligand. Given the documented lower affinity of the A375V mutation, we repeated the
binding assay with this mutant AhR using 20 nM instead of 2 nM [3H]TCDD (Table 4, 20
nM [3H]TCDD column). In addition, several other mutant AhRs which did not bind
[3H]TCDD in the above experiments (i.e., H285M, I332P, M334E, and A375L) were also
examined to confirm their lack of ligand binding activity. The increased concentration of
[3H]TCDD in these assays allowed detection of [3H]TCDD specific binding to the A375V
mutant AhR (17% of wild-type AhR), and the reduced amount of specific binding to this
mutant AhR likely still results from some ligand stripping by the Tween 80 washing steps.
These secondary ligand binding experiments also confirmed the inability of the other mutant
AhRs to specifically bind [3H]-TCDD. Taken together, these mAhR ligand binding assay
results are now in agreement with the ligand-induced DNA binding data. In contrast to the
above results, the E339A mutation is interesting in that it reduced AhR transformation and
DNA binding by 50% with no significant decrease in ligand binding (although a trend of
lower binding was observed). These results could suggest that the E339A mutation exerts a
more specific effect on ligand-dependent transformation events.
Overall, the mutagenesis and functional analysis results are consistent with the proposed
model of the mAhR LBD (mod_HIF/ARNT) and confirm that the cavity modeled in the
interior of the domain is indeed involved in ligand binding.
In fact, mutation of those residues that point outside the modeled LBD pocket (Arg282,
Thr311, Glu339 and Lys350, shown in blue in Figure 4) to alanine do not affect AhR TCDD
binding and, with the exception of Glu339, AhR tranformation/DNA binding. It is
conceivable that Glu339, whose side chain points out of the pocket toward the back of the β-
sheet, is indeed not involved in ligand binding but could affect mAhR transformation by
altering ligand-dependent effects on the interaction of AhR with partner proteins such as
hsp90 or ARNT. This point deserves further in-depth analyses to elucidate the specific sites
for protein–protein interaction on the LBD external surface.
In contrast, those residues whose mutation adversely affects TCDD and/or DNA binding
point into the modeled cavity (His285, Cys327, Met334, Ala375, and Gln377, shown in
purple in Figure 4) or lie in the helical connector that flanks the cavity (I332). Homology
modeling of these mutants, performed on the basis of the same template structures,
alignment, and modeling procedure used for the wild-type mAhR (see Materials and
Methods section), indicated that only the I332P mutation has structural effects on the LBD.
As expected, substitution of isoleucine with proline in that position destabilized the helical
connector due to the loss of a hydrogen bond between the nitrogen (on Ile332) and oxygen
(on Ala328) backbone atoms. The structural effects of this change were evidenced by
performing a 1 ns molecular dynamics simulation (see Materials and Methods section) on
the modeled I332P mutant. After about 300 ps of simulation the kink of the helix around the
E329 position, with insertion of a turn, was evidenced by the DSSP analysis (58). Moreover,
perturbation of the helix N-terminal capping as well as of the orientations of the side chains
from the helix N-terminal to P332 was observed (Figure 7). One of the consequences of
these structural modifications was the reduction in the internal cavity volume of about 100
Å3. It has to be noted that a MD simulation performed on the modeled wild-type mAhR
LBD, with the same computational protocol as for I332P, indicated that, in that case, the
tertiary and secondary structure of the domain remained stable throughout the simulation. It
is therefore conceivable that the complete elimination of TCDD binding and TCDD-
inducible AhR DNA binding observed for the I332P mutant is associated to the loss of LBD
structural features required for ligand binding.
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In contrast, analysis of the models generated for the point mutants in the His285, Cys327,
Met334, Ala375, and Gln377 positions indicated that those mutations did not modify either
the overall fold nor the secondary structure elements of the LBD. Also the side-chain
conformations of residues lying in the modeled cavity and those in the surrounding of the
mutated residue were unaffected in all cases. Therefore, the effects of those mutations on
TCDD binding appear to be related to the removal of specific molecular requirements for
ligand recognition.
Interesting mutations are those of alanine 375 to two residues (valine and leucine) that
maintain its hydrophobicity but present increasingly longer side chains. Previous results
identified the side-chain size in the Ala375 position of the mAhR as critical for ligand
binding activity, since the valine substitution of this residue that is found naturally in the
mouse AhRd allele and in the human AhR significantly reduced ligand binding (16,17,24).
As expected, mutation of Ala375 to valine dramatically reduced [3H]TCDD specific
binding, and ligand binding was eliminated when Ala375 was mutated to leucine (Table 4).
The position of this residue is directly in the center of the modeled LBD cavity, and
decreased TCDD binding must be associated with increased steric hindrance by the amino
acid side chain. Thus, TCDD must bind relatively close to this residue within the cavity for
it to reduce TCDD binding.
The His285 residue is also very interesting in that its mutation to alanine completely
eliminated TCDD binding and TCDD-inducible AhR DNA binding (Table 4). It should be
noted that the His285 side chain lies very close to that of Ala375 whose mutation to valine
or leucine reduces ligand binding due to steric hindrance. The proximity of this side chain to
Ala375 may support the hypothesis that His285 plays a key role in the interaction of the
AhR LBD with TCDD. Moreover for histidine, which is unprotonated at the physiological
pH particularly when it occurs in buried cavities and has the properties of a polar aromatic
residue, π–π interactions with aromatic partners are frequently observed in protein systems
(64). It is therefore conceivable that His285 plays a role in stabilizing interactions with the
AhR aromatic ligands. Binding of TCDD in the pocket may be particularly strengthened by
the high polarizability of the electron distribution of this ligand along the prime molecular
axis (65) that improves dispersion interactions. In addition, this molecular association may
be stabilized by a substantial electrostatic component given the presence of lateral electron-
withdrawing chlorine atoms in the TCDD that generates an electronic charge depletion in
the central part of the molecule including the aromatic rings (66).
On the other hand, the reduction in TCDD binding to mAhRs containing the C327A,
M334A, and Q377A mutations (Table 4) suggests a hypothesis that stabilization of the polar
aromatic ligand could result from a network of weak interactions instead of a specific one.
In fact, sulfur–arene interactions involving methionine and cysteine side chains, mainly due
to dispersion forces between the sulfur atom and the π surface, are frequently recognized in
proteins as well as weak N–H/π hydrogen bonds (67). The decreased contribution of each of
these interactions to the TCDD stabilization, as a result of their mutation to alanine, may
considerably weaken the binding. Strong support for this hypothesis is given by mutation of
Met334 to glutamic acid that completely eliminated AhR ligand binding and ligand-
dependent DNA binding. It is conceivable that the introduction of a side chain carrying a net
negative charge in the molecular environment of the mAhR binding cavity may strongly
perturb the existing network of weak interactions.
Finally, it is also informative to include our preliminary models of the mAhR LBD (23,26)
in the analysis of the relationship between the mutations and their effect on AhR
functionality. While some of the mutagenesis results are also consistent with the LBD
features of both our previous models, some mutations produce effects that cannot be
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rationalized on the basis of those structural proposals. In particular, Arg282 and Glu339,
whose mutations to alanine had no effect on ligand binding and that accordingly reside on
the domain surface in the HIF/ARNT model, lie in key positions within the domain modeled
on the basis of the FixL template (23). Additionally, in the same model, His285, whose
mutation to alanine strongly affects both TCDD and DNA binding, points outside the
modeled cavity. Also, in the model based on Phy3 (26), due to some misalignment errors in
the N-terminal region, the positions of two residues disagree with what is indicated by the
present mutagenesis data: Arg282 was modeled on the inside of the cavity, while His285
was modeled on the external domain surface. These above considerations further support the
higher reliability of the HIF/ARNT model proposed here and confirm that it provides us
with a significantly improved model to study the AhR LBD features.
Not only is the information derived from mutagenesis experiments consistent with the
structural proposal derived from the homology model based on the HIF-2α and ARNT
template structures, but the analysis of experimental results in the framework of the model
also highlights a list of residues contributing to the particular binding affinity of this domain
to aromatic compounds.
CONCLUSIONS
The availability of new structural and functional information on PAS domains has allowed
the development of an updated and reliable model of the mAhR PAS B domain by
homology modeling techniques. While the overall fold features of the domain appeared to
be reproduced independently of the choice of the template structure for modeling,
comparison of different mono- and multitemplate models demonstrated the crucial influence
of this choice on the secondary structure arrangement that determines the features of the
mAhR binding cavity. NMR PAS structures of the HIF-2α and ARNT proteins were
selected as the most reliable templates due to their higher degree of sequence identity and
similarity with the mAhR PAS B and to the functional similarities of the full-length proteins.
The effects of point mutations in selected key residue positions on both [3H]TCDD binding
and TCDD-dependent transformation and DNA binding here analyzed confirmed the
proposed structural features of the mAhR LBD and revealed some inconsistencies with
previous models, thus highlighting the significant improvement given by the newly available
PAS template structures. Our experimental results confirmed the role of the largest structural
cavity identified in the modeled mAhR LBD as the site involved in ligand binding. In fact,
while mutation of those residues that point outside the domain does not affect AhR TCDD
binding, mutation of residues lying in this cavity reduces or eliminates TCDD binding and
TCDD-inducible DNA binding. The identification of a buried cavity within the core of the
mAhR PAS B domain with enough internal space available for ligands highlights the
different functional role of this domain with respect to the HIF-2α and ARNT PAS
structures, whose domain interior is well packed. Moreover, our results are consistent with
the proposed model being more representative of the ligand-bound form of the mAhR rather
than the unliganded form of the AhR.
Some specific structural and chemical requirements for ligand binding were also highlighted
by analyzing the mutagenesis results in the framework of the three-dimensional model. The
dramatic effects of mutating a residue in the central helical connector (Ile332) to the helix-
breaking proline demonstrated the role of this structural element in maintaining the overall
fold of the domain and the topology of the cavity. The hypothesis that TCDD may bind
relatively close to Ala375, in the center of the modeled LBD cavity, was supported by the
adverse effect on TCDD specific binding and ligand-dependent DNA binding to mutants
with increased steric hindrance in that position (A375V and A375L). These results also
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provide an explanation for the lower ligand affinity of the AhR present in human and some
mouse strains, since the presence of a valine residue in this position in the AhR in these
species reduces the accessibility of the ligand within the LBD cavity. The closeness of the
His285 side chain to that of Ala375 in the proposed model, along with its electronic
characteristics that suggest its involvement in the TCDD stabilization, is in complete
agreement with the observed loss of AhR TCDD binding and TCDD-inducible DNA
binding activity due to its mutation to alanine. Moreover, partial reduction of TCDD and
DNA binding associated with the mutation of some hydrophobic or polar residues in the
boundary of the modeled cavity suggested that a network of weak interactions involving
these residues is the molecular determinant for stabilization of TCDD binding within the
LBD. The dramatic effects of introducing a charged residue (M334E mutant) within this
environment confirmed this hypothesis.
In contrast to the results where the effects on ligand binding and ligand-inducible DNA
binding activity are correlated and are most likely linked, a divergence in these functional
activities was observed with the E339A mutation. Mutation of E339, whose side chain
points outside the binding cavity toward the back of the β-sheet, resulted in reduced ligand-
dependent AhR DNA binding but no significant decrease of ligand [3H]TCDD binding.
These results suggest this region as a putative site for protein–protein interactions that could
be involved in the ligand-dependent mAhR transformation. Further analysis of this
possibility needs to be performed.
In conclusion, the agreement between this first set of site-directed mutagenesis experiments
and modeling results not only confirms and validates the structural features of this improved
homology model of the mAhR PAS B LBD but it also provides a framework for developing
and testing further hypotheses on the key events involved in the mechanisms of ligand
binding and ligand-dependent activation of the AhR.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1.
Cartoon representation of the PAS domain structures included in the analysis with their
cofactors: HIF-2α (PDB ID 1P97), ARNT (PDB ID 1X0O), dPER (PDB ID 1WA9), HERG
(PDB ID 1BYW), hPASK (PDB ID 1LL8), Phy3 (PDB ID 1G28), NCoA (PDB ID 1OJ5),
FixL (PDB ID 1DRM), and PYP (PDB ID 1NWZ). Secondary structure attribution was
according to the Kabsch and Sander method (58). For FixL and PYP the additional extra-
domain elements included in the X-ray structures are also included (a long helix at the C-
terminus for FixL and an N-terminal bundle of two helices for PYP).
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FIGURE 2.
(a) Diagram of the typical PAS fold with secondary structure elements labeled according to
the nomenclature generally adopted for the PAS structures. (b) Sequence alignment of the
mAhR against the templates HIF-2α and ARNT, pairwise aligned according to DALI. Only
residues that are identical or similar for at least two of the three sequences are highlighted by
colors. Coloring scheme for residues: red, acidic; blue, basic; purple, polar; yellow, Cys;
brown, aromatic; green, hydrophobic; orange, Ser, Thr; gray, Pro, Gly. The mAhR predicted
secondary structure and the template secondary structures, attributed according to the
method of Kabsch and Sander (58), are also shown. Helices and β-strands are represented as
white and black bars, respectively, and labeled with the PAS structure nomenclature (see
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panel a). Red arrows indicate the boundary residues of the mAhR cavity that have
considerably smaller side chains than the corresponding ones in HIF-2α.
Pandini et al. Page 21
Biochemistry. Author manuscript; available in PMC 2010 April 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIGURE 3.
(a) Cartoon representation of the three modeled structures of the mAhR LBD. (b) Stick and
cartoon representations of the model based on the HIF-2α and ARNT template structures
(mod_HIF/ARNT) in different orientations, with the molecular surface (in blue) including
the available volume in the cavity identified by CASTp. Secondary structure attribution was
according to the method of Kabsch and Sander (58).
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FIGURE 4.
Cartoon representation of the modeled mAhR LBD (mod_HIF/ARNT) showing selected
residues that were mutated. Residues with side chains pointing outside the modeled LBD are
shown in blue; boundary residues of the cavity with side chains pointing inside it are shown
in purple; Ile332, which is expected to have a structural role, is shown in yellow. The
molecular surface (in green) including the available volume in the cavity identified by
CASTp is shown.
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FIGURE 5.
Effect of mutation of selected residues within the mAhR LBD on TCDD-dependent AhR
DNA binding. In vitro expressed wild-type or mutant AhR and wt ARNT were incubated
with TCDD, and inducible AhR–ARNT–DRE complex formation was determined by gel
retardation analysis as described under Materials and Methods. The positions of the induced
AhR–ARNT–DRE complex are indicated by an arrow. Quantitation of the amount of the
TCDD–AhR–ARNT–DRE complex was determined by phosphorimager analysis, and the
results of multiple receptor preparations and gel retardation analyses (n ≥ 3) are presented in
Table 4.
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FIGURE 6.
Expression levels of in vitro synthesized wild-type and mutant AhRs. 35S-Labeled wild-type
and mutant AhRs were synthesized in vitro, denatured, and resolved by SDS–
polyacrylamide gel electrophoresis and autoradiography of the dried gels as described in
Materials and Methods. An arrow shows the bands of the AhR.
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FIGURE 7.
Stick representation of the helical connector main chain in the modeled mAhR LBD
subjected to 1 ns MD simulation: (a) wild-type mAhR; (b) I332P mutant. The coloring
scheme is according to the atom types. Hydrogen bonds are highlighted in yellow. Cartoon
representation of the domain is shown in transparency.
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Table 1
PDB Identification Numbers of the PAS Domain Structures Employed
PDB ID protein structure method ref
1P97 human hypoxia-inducible factor, HIF-2α NMR (26 structures) 28
1X0O human aryl hydrocarbon receptor nuclear translocator, ARNT NMR (20 structures) 31
1WA9a Drosophila clock protein PERIOD, dPER X-ray diffraction 30
1BYW human erg potassium channel, HERG X-ray diffraction 21
1LL8 human PAS kinase, hPASK NMR (20 structures) 27
1G28b Adiantum capillus-veneris chimeric phytochrome/
 phototropin photoreceptor, Phy3
X-ray diffraction 25
1OJ5 mouse steroid receptor coactivator 1A, NCoA X-ray diffraction 29
1DRM Bradyrhizobium japonicum sensor protein Fixl, FixL X-ray diffraction 22
1NWZ Ectothiorhodospira halophila photoactive yellow protein, PYP X-ray diffraction 35
a
Chain A was employed and only the region encompassing the PAS B domain was included in the alignment. The location of this region was
derived by structural alignment with HIF-2α
b
Chain A was employed.
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Table 2
Sequence Identity and Similarity between PAS Domain Templates and the mAhRa
PAS domain identity (%)
similarity (%)
(BLOSUM 62)
no. of aligned positions
(including gaps)
HIF-2α 31.1 62.1 103
ARNT 21.2 53.8 104
dPER 16.7 45.4 108
HERG 12.0 41.7 108
hPASK 11.9 41.3 109
Phy3 11.1 40.7 108
NCoA 10.3 38.8 116
FixL 10.3 36.4 107
PYP 6.7 32.4 105
a
See text for more details.
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Table 3
PROSA z-Score Values for the Three AhR PAS B Models
PROSA z-score
model mean (100 models) SD best model
mod_HIF-2α −4.00 0.20 −4.03
mod_HIF/ARNT −4.53 0.26 −4.56
mod_8templates −4.71 0.24 −4.58
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Table 4
Effect of Mutagenesis of Individual Amino Acids within the mAhR LBD on [3H]TCDD Specific Binding and
TCDD-Inducible AhR DNA Binding
[3H]TCDD specific binding
mutant
DRE binding
(% of wt AhR)
2 nM [3H]TCDD
(% of wt AhR)
20 nM [3H]TCDD
(% of wt AhR)
wild-type
 AhR
100 100 ± 19a 100 ± 3
R282A 125 ± 22 76 ± 2 NDc
H285A −2.3 ± 4b 4 ± 7b 3 ± 5b
T311A 97 ± 21 91 ± 15 ND
C327A 82 ± 11b 59 ± 3b ND
I332P −10 ± 10b −4 ± 2b 2 ± 1b
M334A 70 ± 9b 57 ± 7b ND
M334E 3 ± 6b −16 ± 12b 3 ± 1b
E339A 53 ± 8b 75 ± 12 ND
K350A 95 ± 11 94 ± 4 ND
A375V 42 ± 12b −6 ± 7b 17 ± 1b
A375L 2.8 ± 8b −2 ± 17b 1 ± 2b
Q377A 52 ± 3b 31 ± 4b ND
a
Values represent the mean ± SD of three to five individual analyses.
b
Values are significantly different from wild-type mAhR at P ≤ 0.05 as determined by Student’s t-test.
c
Not determined.
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